NovalGen
Manufacturing · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Argyle House Joel St, London, Greater Lo...Phone Number
+44 2071398639Website
www.novalgen.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About NovalGen
NovalGen is a clinical-stage biotechnology company specializing in innovative multi-specific antibody therapies aimed at transforming treatment outcomes in oncology, autoimmune, haematological, and metabolic disorders. The company utilizes its groundbreaking AutoRegulation platform technology to develop safer and more efficient immunotherapies tailored to improve clinical outcomes. NovalGen collaborates with academic institutions and strategic partners to advance its pipeline of next-generation biologics. Their mission is to change the paradigm of immunotherapies and enhance the lives of patients through their advanced therapeutic solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NovalGen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when NovalGen launches new products
Website visits: Recent activity has been detected on your website
Check if NovalGen has recently received funding, and reach out quickly before it becomes old news!
Click to see if NovalGen had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at NovalGen
Funding: Get notified immidiatlly once NovalGen has new funding data
Check out if NovalGen is spiking on competitors!
Earning: See what the market has to say on NovalGen recently announced quarterly report
NovalGen, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to NovalGen
Compare insights from companies similar to NovalGen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NovalGen
<$5M
11-50
Private
-
2019
N/A
Company Profile Activity
Activity Insights
NovalGen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NovalGen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NovalGen.
NovalGen Tech Stack
A closer look at the technologies used by NovalGen
See more technologies
NovalGen News & Media
NovalGen to Begin World’s First Clinical Trial for a Self-Regulating Immunotherapy
Groundbreaking cancer therapy that self-inactivates when there is risk of toxicity approved by MHRA for entry into Phase I clinical trialNovalGen appoints Dr Michael Owen and Mr Scott Clark to the Board of Directors
Two highly experienced industry executives who bring a wealth of leadership and drug development experience Two highly experienced industry executives who bring a wealth of leadership and drug development experienceNovalGen announces one oral and two poster presentations at the American Society of Hematology Annual Meeting
-Updated clinical data for NVG-111, a novel ROR1xCD3 bispecific antibody in patients with relapsed / refractory CLL and MCL - - Pre-clinical data for a first in class half-life extended T Cell engager targeting ROR-1-NovalGen announces compelling data from the Phase 1/2 Study of NVG-111 at the ASCO Annual Meeting
- First clinical data for NVG-111, a novel ROR1xCD3 bispecific antibody in patients with relapsed / refractory CLL and MCL
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NovalGen
Sign Up For FreeTo access detailed company insights
NovalGen is a clinical-stage biotechnology company specializing in innovative multi-specific antibody therapies aimed at transforming treatment outcomes in oncology, autoimmune, haematological, and metabolic disorders. The company utilizes its groundbreaking AutoRegulation platform technology to develop safer and more efficient immunotherapies tail... Read More
